276 related articles for article (PubMed ID: 26297026)
1. Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors.
Garwood CJ; Ratcliffe LE; Morgan SV; Simpson JE; Owens H; Vazquez-Villaseñor I; Heath PR; Romero IA; Ince PG; Wharton SB
Mol Brain; 2015 Aug; 8():51. PubMed ID: 26297026
[TBL] [Abstract][Full Text] [Related]
2. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.
Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ
J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910
[TBL] [Abstract][Full Text] [Related]
3. A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression.
Chrudinová M; Kirk NS; Chuard A; Venugopal H; Zhang F; Lubos M; Gelfanov V; Páníková T; Žáková L; Cutone J; Mojares M; DiMarchi R; Jiráček J; Altindis E
Mol Metab; 2024 Feb; 80():101863. PubMed ID: 38182007
[TBL] [Abstract][Full Text] [Related]
4. Novel nuclear localization and potential function of insulin-like growth factor-1 receptor/insulin receptor hybrid in corneal epithelial cells.
Wu YC; Zhu M; Robertson DM
PLoS One; 2012; 7(8):e42483. PubMed ID: 22879999
[TBL] [Abstract][Full Text] [Related]
5. Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor.
Vincent EE; Elder DJ; Curwen J; Kilgour E; Hers I; Tavaré JM
PLoS One; 2013; 8(6):e66963. PubMed ID: 23826179
[TBL] [Abstract][Full Text] [Related]
6. Impaired IGF1R signaling in cells expressing longevity-associated human IGF1R alleles.
Tazearslan C; Huang J; Barzilai N; Suh Y
Aging Cell; 2011 Jun; 10(3):551-4. PubMed ID: 21388493
[TBL] [Abstract][Full Text] [Related]
7. Loss of IGF1R in Human Astrocytes Alters Complex I Activity and Support for Neurons.
Ratcliffe LE; Vázquez Villaseñor I; Jennings L; Heath PR; Mortiboys H; Schwartzentruber A; Karyka E; Simpson JE; Ince PG; Garwood CJ; Wharton SB
Neuroscience; 2018 Oct; 390():46-59. PubMed ID: 30056117
[TBL] [Abstract][Full Text] [Related]
8. Deciphering Brain Insulin Receptor and Insulin-Like Growth Factor 1 Receptor Signalling.
Kleinridders A
J Neuroendocrinol; 2016 Nov; 28(11):. PubMed ID: 27631195
[TBL] [Abstract][Full Text] [Related]
9. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.
Moloney AM; Griffin RJ; Timmons S; O'Connor R; Ravid R; O'Neill C
Neurobiol Aging; 2010 Feb; 31(2):224-43. PubMed ID: 18479783
[TBL] [Abstract][Full Text] [Related]
10. Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling.
Sciacca L; Cassarino MF; Genua M; Pandini G; Le Moli R; Squatrito S; Vigneri R
Diabetologia; 2010 Aug; 53(8):1743-53. PubMed ID: 20424816
[TBL] [Abstract][Full Text] [Related]
11. Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia.
Zemva J; Schubert M
Curr Diabetes Rev; 2011 Sep; 7(5):356-66. PubMed ID: 21916834
[TBL] [Abstract][Full Text] [Related]
12. Insulin and IGF1 receptors in human cardiac microvascular endothelial cells: metabolic, mitogenic and anti-inflammatory effects.
Bäck K; Islam R; Johansson GS; Chisalita SI; Arnqvist HJ
J Endocrinol; 2012 Oct; 215(1):89-96. PubMed ID: 22825921
[TBL] [Abstract][Full Text] [Related]
13. Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer.
Buck E; Gokhale PC; Koujak S; Brown E; Eyzaguirre A; Tao N; Rosenfeld-Franklin M; Lerner L; Chiu MI; Wild R; Epstein D; Pachter JA; Miglarese MR
Mol Cancer Ther; 2010 Oct; 9(10):2652-64. PubMed ID: 20924128
[TBL] [Abstract][Full Text] [Related]
14. Human microvascular endothelial cells are sensitive to IGF-I but resistant to insulin at the receptor level.
Johansson GS; Chisalita SI; Arnqvist HJ
Mol Cell Endocrinol; 2008 Dec; 296(1-2):58-63. PubMed ID: 18708119
[TBL] [Abstract][Full Text] [Related]
15. Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling.
Varewijck AJ; Brugts MP; Frystyk J; Goudzwaard JA; Uitterlinden P; Waaijers AM; Feng Y; Dimitrov DS; Lamberts SW; Hofland LJ; Janssen JA
Mol Cell Endocrinol; 2013 Jan; 365(1):17-24. PubMed ID: 22982059
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like modulation of Akt/FoxO signaling by copper ions is independent of insulin receptor.
Hamann I; Petroll K; Grimm L; Hartwig A; Klotz LO
Arch Biochem Biophys; 2014 Sep; 558():42-50. PubMed ID: 24933099
[TBL] [Abstract][Full Text] [Related]
17. Insulin receptor (IR) pathway hyperactivity in IGF-IR null cells and suppression of downstream growth signaling using the dual IGF-IR/IR inhibitor, BMS-754807.
Dinchuk JE; Cao C; Huang F; Reeves KA; Wang J; Myers F; Cantor GH; Zhou X; Attar RM; Gottardis M; Carboni JM
Endocrinology; 2010 Sep; 151(9):4123-32. PubMed ID: 20610571
[TBL] [Abstract][Full Text] [Related]
18. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vimentin interacts with insulin-like growth factor 1 receptor to promote axonal growth.
Shigyo M; Kuboyama T; Sawai Y; Tada-Umezaki M; Tohda C
Sci Rep; 2015 Jul; 5():12055. PubMed ID: 26170015
[TBL] [Abstract][Full Text] [Related]
20. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
Sarfstein R; Nagaraj K; LeRoith D; Werner H
Cells; 2019 Nov; 8(12):. PubMed ID: 31771180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
